SCHEMBL6715966

SCHEMBL6715966

COc1ccc(-c2ccc(C(=O)NCCOc3ccc(CC(Oc4ccc(C(C)C)cc4)C(=O)O)cc3)cn2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GCG P01275 1/20 0.49
HCAR2 Q8TDS4 3/20 0.47
NPC1 O15118 2/20 0.46
ALDH1A1 P00352 1/20 0.46
RAB9A P51151 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
PPARG P37231 5/20 0.44
PPARA Q07869 5/20 0.44
TRPV1 Q8NER1 1/20 0.44
RXFP1 Q9HBX9 1/20 0.42
MMP9 P14780 1/20 0.42
MMP12 P39900 1/20 0.42
DGAT1 O75907 1/20 0.41
TP53 P04637 1/20 0.41
MAPT P10636 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
PPARD Q03181 1/20 0.41
CXCR3 P49682 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6715146 0.95 GCG (0.53) GCGHCAR2NPC1ALDH1A1RAB9A
SCHEMBL6715079 0.93 GCG (0.48) GCGHCAR2PPARGPPARATRPV1
SCHEMBL6713208 0.93 GCG (0.48) GCGHCAR2ALDH1A1RAB9APPARG
SCHEMBL6712975 0.91 GCG (0.47) GCGHCAR2NPC1ALDH1A1RAB9A
SCHEMBL6722193 0.90 NPC1 (0.54) HCAR2NPC1ALDH1A1RAB9ASMN1; SMN2
SCHEMBL6712961 0.88 GCG (0.49) GCGHCAR2NPC1ALDH1A1RAB9A
SCHEMBL6713102 0.88 GCG (0.49) GCGHCAR2NPC1RAB9APPARG
SCHEMBL6715826 0.86 MAPT (0.49) GCGHCAR2NPC1ALDH1A1RAB9A
SCHEMBL6715209 0.86 GCG (0.51) GCGHCAR2NPC1ALDH1A1RAB9A
SCHEMBL6715252 0.86 PPARG (0.47) GCGNPC1RAB9ASMN1; SMN2PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6528525-B1 Amidocarboxylic acid derivatives SANKYO COMPANY, LIMITED (JP) 2003-03-04 US claimed
EP-1026149-A1 AMIDOCARBOXYLIC ACID DERIVATIVES Sankyo Company Limited (JP) 2000-08-09 EP claimed
US-20040006141-A1 Amidocarboxylic acid compounds SANKYO COMPANY, LTD (JP) 2004-01-08 US disclosed
US-6528525-B1 Amidocarboxylic acid derivatives SANKYO COMPANY, LIMITED (JP) 2003-03-04 US disclosed
EP-1026149-A1 AMIDOCARBOXYLIC ACID DERIVATIVES Sankyo Company Limited (JP) 2000-08-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040006141-A1 Amidocarboxylic acid compounds NR1H2, AGK, APOL1 GCG 78/4885HCAR2 429/4885NPC1 812/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.